Fibromuscular dysplasia: Difference between revisions

From IDWiki
(Imported from text file)
 
m (Text replacement - "Clinical Presentation" to "Clinical Manifestations")
Line 6: Line 6:
* Segmental arterial mediolysis
* Segmental arterial mediolysis


== Clinical Presentation ==
== Clinical Manifestations ==


* Arteries involved:
* Arteries involved:

Revision as of 10:16, 22 July 2020

Differential Diagnosis

  • Standing waves caused by contrast-induced spasm
  • Atherosclerosis
  • Vasculitis
  • Segmental arterial mediolysis

Clinical Manifestations

  • Arteries involved:
    • Renal 58%
    • Carotid or vertebral 32%
    • Other arteries including iliac and intracranial 10%

Renal artery FMD

  • Hypertension, especialy early-onset <35 years or drug-resistant
    • Average age of onset 43 years
  • Epigastric or flank bruit
  • Flank pain if dissection or aneurysm
  • Progression to end-stage renal disease is rare

Cerebrovascular FMD

  • Headache is most common complaint, usually migrainous
  • Pulsatile tinnitus
  • Dizziness or lightheadedness
  • Cervical bruit
  • Neck pain
  • TIA or stroke
  • Carotid and vertebral artery dissections, presenting with headache and neck pain, cranial nerve deficits, or Horner syndrome
  • Can cause cerebral aneurysms

Mesenteric FMD

  • Rare, often incidental finding
  • Can cause mesenteric ischemia

FMD of the extremities

  • Most commonly the external iliac arteries, though can involved brachial arteries as well
  • Often asymptomatic, or claudication; rarely, acute ischemia
  • May have a lower abdominal or inguinal bruit

FMD of the coronary arteries

  • Can present as an acute coronary syndrome, though rare

Diagnosis

  • CT or MR angiography or Duplex ultrasound

Management

Renal artery revascularization

Indications

  • Resistant hypertension despite 3-drug regimen including diuretic
  • Recent-onset hypertension, with the goal of curing it
  • Renal artery dissection (needs stenting)
  • Renal artery aneurysm
  • Branch renal artery disease and hypertension
  • Preservation of renal function if severe stenosis

Chronic

Screening

  • All patients with FMD anywhere are recommended to be screened for intracranial aneurysms with CTA or MRA

Hypertension

  • First-line is ACEi/ARB
  • Can consider percutaneous transluminal angioplasty

Dissection

  • LMWH or wardarin for 3 to 6 months, or antiplatelet therapy

Follow-up

  • Monitor blood pressure and creatinine every three months, then annually if stable
  • Duplex ultrasound or other noninvasive imaging of the involved arteries every 6 to 12 months

Further Reading